She died on 21 April after six years with young-onset disease and had joined the Colorectal Cancer Alliance in January 2025 to push for more federal research funding.
Sayas previously advised the Biden White House on infectious disease and cancer, contributed to the Cancer Moonshot, and had worked for Senator Amy Klobuchar, amfAR and Capitol Hill offices.
Tributes from Jill Biden, Klobuchar and cancer specialists highlighted her advocacy as young-onset colorectal cancer rises and mortality progress stalls, especially among patients diagnosed before age 50.
Why do deadly cancers like colorectal receive less research funding per death, and how can this disparity be fixed?
As colorectal cancer surges in the young, what hidden environmental or dietary triggers are researchers now urgently investigating?
With new AI and blood tests emerging, will the invasive colonoscopy soon become obsolete for cancer screening?
Asal Sayas and the Battle Against Young-Onset Colorectal Cancer: Policy, Awareness, and Research Advances
Overview
Asal Sayas, a dedicated cancer policy advocate, passed away in 2026 after a six-year battle with young-onset colorectal cancer, a disease rising sharply among adults under 50. Her death sparked widespread tributes and solidified her legacy as a transformative figure in cancer advocacy. Diagnosed at stage IV in 2020, Sayas intensified her efforts by joining the White House Cancer Moonshot initiative, co-founding Colorectal Cancer Change, and collaborating on research funding projects. She challenged perceptions by continuing her work despite advanced illness, inspiring many with her courage. Her advocacy helped lower the recommended screening age to 45 and continues to drive legislative efforts to improve early detection, research funding, and health equity.